Reviews
9 November 2021

Current Insights Into Respiratory Virus Transmission and Potential Implications for Infection Control Programs: A Narrative Review

Publication: Annals of Internal Medicine
Volume 174, Number 12

Abstract

Policies to prevent respiratory virus transmission in health care settings have traditionally divided organisms into Droplet versus Airborne categories. Droplet organisms (for example, influenza) are said to be transmitted via large respiratory secretions that rapidly fall to the ground within 1 to 2 meters and are adequately blocked by surgical masks. Airborne pathogens (for example, measles), by contrast, are transmitted by aerosols that are small enough and light enough to carry beyond 2 meters and to penetrate the gaps between masks and faces; health care workers are advised to wear N95 respirators and to place these patients in negative-pressure rooms. Respirators and negative-pressure rooms are also recommended when caring for patients with influenza or SARS-CoV-2 who are undergoing “aerosol-generating procedures,” such as intubation. An increasing body of evidence, however, questions this framework. People routinely emit respiratory particles in a range of sizes, but most are aerosols, and most procedures do not generate meaningfully more aerosols than ordinary breathing, and far fewer than coughing, exercise, or labored breathing. Most transmission nonetheless occurs at close range because virus-laden aerosols are most concentrated at the source; they then diffuse and dilute with distance, making long-distance transmission rare in well-ventilated spaces. The primary risk factors for nosocomial transmission are community incidence rates, viral load, symptoms, proximity, duration of exposure, and poor ventilation. Failure to appreciate these factors may lead to underappreciation of some risks (for example, overestimation of the protection provided by medical masks, insufficient attention to ventilation) or misallocation of limited resources (for example, reserving N95 respirators and negative-pressure rooms only for aerosol-generating procedures or requiring negative-pressure rooms for all patients with SARS-CoV-2 infection regardless of stage of illness). Enhanced understanding of the factors governing respiratory pathogen transmission may inform the development of more effective policies to prevent nosocomial transmission of respiratory pathogens.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
World Health Organization. Coronavirus disease (COVID-19): how is it transmitted? 13 December 2020; updated 30 April 2021. Accessed at www.who.int/news-room/q-a-detail/coronavirus-disease-covid-19-how-is-it-transmitted on 14 May 2021.
2.
Centers for Disease Control and Prevention. Scientific brief: SARS-CoV-2 transmission. Updated 7 May 2021. Accessed at www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/sars-cov-2-transmission.html on 14 May 2021.
3.
Chen W, Zhang N, Wei J, et al. Short-range airborne route dominates exposure of respiratory infection during close contact. Build Environ. 2020;176:106859. doi: 10.1016/j.buildenv.2020.106859
4.
Morawska L, Johnson GR, Ristovski ZD, et al. Size distribution and sites of origin of droplets expelled from the human respiratory tract during expiratory activities. J Aerosol Science. 2009;40:256-9. doi: 10.1016/j.jaerosci.2008.11.002
5.
Greenhalgh TJimenez JLPrather KAet al. Ten scientific reasons in support of airborne transmission of SARS-CoV-2. Lancet. 2021;397:1603-1605. [PMID: 33865497]  doi: 10.1016/S0140-6736(21)00869-2
6.
Bourouiba L. Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of COVID-19. JAMA. 2020;323:1837-1838. [PMID: 32215590] doi: 10.1001/jama.2020.4756
7.
Edwards DA, Ausiello D, Salzman J, et al. Exhaled aerosol increases with COVID-19 infection, age, and obesity. Proc Natl Acad Sci U S A. 2021;118. [PMID: 33563754] doi: 10.1073/pnas.2021830118
8.
Coleman KK, Tay DJW, Sen Tan K, et al. Viral load of SARS-CoV-2 in respiratory aerosols emitted by COVID-19 patients while breathing, talking, and singing. Clin Infect Dis. 2021. [PMID: 34358292] doi: 10.1093/cid/ciab691
9.
Johansson MA, Quandelacy TM, Kada S, et al. SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA Netw Open. 2021;4:e2035057. [PMID: 33410879] doi: 10.1001/jamanetworkopen.2020.35057
10.
Leung NH, Xu C, Ip DK, et al. Review article: the fraction of influenza virus infections that are asymptomatic: a systematic review and meta-analysis. Epidemiology. 2015;26:862-72. [PMID: 26133025] doi: 10.1097/EDE.0000000000000340
11.
Lindsley WG, Blachere FM, Davis KA, et al. Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic. Clin Infect Dis. 2010;50:693-8. [PMID: 20100093] doi: 10.1086/650457
12.
Lindsley WG, Blachere FM, Thewlis RE, et al. Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS One. 2010;5:e15100. [PMID: 21152051] doi: 10.1371/journal.pone.0015100
13.
Lindsley WG, Blachere FM, Beezhold DH, et al. Viable influenza A virus in airborne particles expelled during coughs versus exhalations. Influenza Other Respir Viruses. 2016;10:404-13. [PMID: 26991074] doi: 10.1111/irv.12390
14.
Gralton J, Tovey ER, McLaws ML, et al. Respiratory virus RNA is detectable in airborne and droplet particles. J Med Virol. 2013;85:2151-9. [PMID: 23959825] doi: 10.1002/jmv.23698
15.
Stelzer-Braid S, Oliver BG, Blazey AJ, et al. Exhalation of respiratory viruses by breathing, coughing, and talking. J Med Virol. 2009;81:1674-9. [PMID: 19626609] doi: 10.1002/jmv.21556
16.
Leung NHL, Chu DKW, Shiu EYC, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020;26:676-680. [PMID: 32371934] doi: 10.1038/s41591-020-0843-2
17.
Fennelly KP. Particle sizes of infectious aerosols: implications for infection control. Lancet Respir Med. 2020;8:914-924. [PMID: 32717211] doi: 10.1016/S2213-2600(20)30323-4
18.
Yan J, Grantham M, Pantelic J, et al; EMIT Consortium. Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community. Proc Natl Acad Sci U S A. 2018;115:1081-1086. [PMID: 29348203] doi: 10.1073/pnas.1716561115
19.
Siegel JD, Rhinehart E, Jackson M, et al; Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Updated July 2019. Accessed at www.cdc.gov/infectioncontrol/guidelines/isolation/index.html on 24 June 2021.
20.
Wells WF. On air-borne infection. Study II. Droplets and droplet nuclei. Am J Epidemiol. 1934;20:611-8. doi: 10.1093/oxfordjournals.aje.a118097
21.
Wells WF, Ratcliffe HL, Grumb C. On the mechanics of droplet nuclei infection; quantitative experimental air-borne tuberculosis in rabbits. Am J Hyg. 1948;47:11-28. [PMID: 18921435] doi: 10.1093/oxfordjournals.aje.a119179
22.
Randall K, Ewing ET, Marr LC, et al. How did we get here: what are droplets and aerosols and how far do they go? A historical perspective on the transmission of respiratory infectious diseases. Interface Focus. 2021;11:20210049. doi: 10.1098/rsfs.2021.0049
23.
Tang JW, Marr LC, Li Y, et al. Covid-19 has redefined airborne transmission [Editorial]. BMJ. 2021;373:n913. [PMID: 33853842] doi: 10.1136/bmj.n913
24.
Ehresmann KR, Hedberg CW, Grimm MB, et al. An outbreak of measles at an international sporting event with airborne transmission in a domed stadium. J Infect Dis. 1995;171:679-83. [PMID: 7876616] doi: 10.1093/infdis/171.3.679
25.
Marks M, Millat-Martinez P, Ouchi D, et al. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study. Lancet Infect Dis. 2021;21:629-636. [PMID: 33545090] doi: 10.1016/S1473-3099(20)30985-3
26.
Lee LYW, Rozmanowski S, Pang M, et al. SARS-CoV-2 infectivity by viral load, S gene variants and demographic factors and the utility of lateral flow devices to prevent transmission. Clin Infect Dis. 2021. [PMID: 33972994] doi: 10.1093/cid/ciab421
27.
Kawasuji H, Takegoshi Y, Kaneda M, et al. Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients. PLoS One. 2020;15:e0243597. [PMID: 33296437] doi: 10.1371/journal.pone.0243597
28.
Doung-Ngern P, Suphanchaimat R, Panjangampatthana A, et al. Case-control study of use of personal protective measures and risk for SARS-CoV 2 infection, Thailand. Emerg Infect Dis. 2020;26:2607-2616. [PMID: 32931726] doi: 10.3201/eid2611.203003
29.
Bischoff WE, Swett K, Leng I, et al. Exposure to influenza virus aerosols during routine patient care. J Infect Dis. 2013;207:1037-46. [PMID: 23372182] doi: 10.1093/infdis/jis773
30.
Lam-Hine T, McCurdy SA, Santora L, et al. Outbreak associated with SARS-CoV-2 B.1.617.2 (Delta) variant in an elementary school - Marin County, California, May-June 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1214-1219. [PMID: 34473683] doi: 10.15585/mmwr.mm7035e2
31.
Hu M, Lin H, Wang J, et al. Risk of coronavirus disease 2019 transmission in train passengers: an epidemiological and modeling study. Clin Infect Dis. 2021;72:604-610. [PMID: 32726405] doi: 10.1093/cid/ciaa1057
32.
Hamner L, Dubbel P, Capron I, et al. High SARS-CoV-2 attack rate following exposure at a choir practice - Skagit County, Washington, March 2020. MMWR Morb Mortal Wkly Rep. 2020;69:606-610. [PMID: 32407303] doi: 10.15585/mmwr.mm6919e6
33.
Miller SL, Nazaroff WW, Jimenez JL, et al. Transmission of SARS-CoV-2 by inhalation of respiratory aerosol in the Skagit Valley Chorale superspreading event. Indoor Air. 2021;31:314-323. [PMID: 32979298] doi: 10.1111/ina.12751
34.
Lu J, Gu J, Li K, et al. COVID-19 outbreak associated with air conditioning in restaurant, Guangzhou, China, 2020. Emerg Infect Dis. 2020;26:1628-1631. [PMID: 32240078] doi: 10.3201/eid2607.200764
35.
Li Y, Qian H, Hang J, et al. Probable airborne transmission of SARS-CoV-2 in a poorly ventilated restaurant. Build Environ. 2021;196:107788. [PMID: 33746341] doi: 10.1016/j.buildenv.2021.107788
36.
Shen Y, Li C, Dong H, et al. Community outbreak investigation of SARS-CoV-2 transmission among bus riders in eastern China. JAMA Intern Med. 2020;180:1665-1671. [PMID: 32870239] doi: 10.1001/jamainternmed.2020.5225
37.
Olmedo I, Nielsen PV, Ruiz de Adana M, et al. Distribution of exhaled contaminants and personal exposure in a room using three different air distribution strategies. Indoor Air. 2012;22:64-76. [PMID: 21815935] doi: 10.1111/j.1600-0668.2011.00736.x
38.
Wei J, Li Y. Airborne spread of infectious agents in the indoor environment. Am J Infect Control. 2016;44:S102-8. [PMID: 27590694] doi: 10.1016/j.ajic.2016.06.003
39.
Nardell EA, Nathavitharana RR. Airborne spread of SARS-CoV-2 and a potential role for air disinfection. JAMA. 2020;324:141-142. [PMID: 32478797] doi: 10.1001/jama.2020.7603
40.
Buonanno M, Welch D, Shuryak I, et al. Far-UVC light (222 nm) efficiently and safely inactivates airborne human coronaviruses. Sci Rep. 2020;10:10285. [PMID: 32581288] doi: 10.1038/s41598-020-67211-2
41.
Garzona-Navas A, Sajgalik P, Csecs I, et al. Mitigation of aerosols generated during exercise testing with a portable high-efficiency particulate air filter with fume hood. Chest. 2021;160:1388-1396. [PMID: 33895130] doi: 10.1016/j.chest.2021.04.023
42.
Lindsley WG, Derk RC, Coyle JP, et al. Efficacy of portable air cleaners and masking for reducing indoor exposure to simulated exhaled SARS-CoV-2 aerosols - United States, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:972-976. [PMID: 34237047] doi: 10.15585/mmwr.mm7027e1
43.
Cheng HY, Jian SW, Liu DP, et al; Taiwan COVID-19 Outbreak Investigation Team. Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset. JAMA Intern Med. 2020;180:1156-1163. [PMID: 32356867] doi: 10.1001/jamainternmed.2020.2020
44.
Luo L, Liu D, Liao X, et al. Contact settings and risk for transmission in 3410 close contacts of patients with COVID-19 in Guangzhou, China: a prospective cohort study. Ann Intern Med. 2020;173:879-887. [PMID: 32790510] doi: 10.7326/M20-2671
45.
Grijalva CG, Rolfes MA, Zhu Y, et al. Transmission of SARS-COV-2 infections in households - Tennessee and Wisconsin, April-September 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1631-1634. [PMID: 33151916] doi: 10.15585/mmwr.mm6944e1
46.
Canha N, Teixeira C, Figueira M, et al. How is indoor air quality during sleep? A review of field studies. Atmosphere. 2021;12:110. doi: 10.3390/atmos12010110
47.
Karan A, Klompas M, Tucker R, et al; CDC Prevention Epicenters Program. The risk of SARS-CoV-2 transmission from patients with undiagnosed Covid-19 to roommates in a large academic medical center. Clin Infect Dis. 2021. [PMID: 34145449] doi: 10.1093/cid/ciab564
48.
Trannel AM, Kobayashi T, Dains A, et al. Coronavirus disease 2019 (COVID-19) incidence after exposures in shared patient rooms in a tertiary-care center in Iowa, July 2020-May 2021. Infect Control Hosp Epidemiol. 2021:1-4. [PMID: 34250882] doi: 10.1017/ice.2021.313
49.
Cheng VC, Fung KS, Siu GK, et al. Nosocomial outbreak of coronavirus disease 2019 by possible airborne transmission leading to a superspreading event. Clin Infect Dis. 2021;73:e1356-e1364. [PMID: 33851214] doi: 10.1093/cid/ciab313
50.
Klompas M, Baker MA, Rhee C, et al. A SARS-CoV-2 cluster in an acute care hospital. Ann Intern Med. 2021;174:794-802. [PMID: 33556277] doi: 10.7326/M20-7567
51.
Edwards DA, Man JC, Brand P, et al. Inhaling to mitigate exhaled bioaerosols. Proc Natl Acad Sci U S A. 2004;101:17383-8. [PMID: 15583121] doi: 10.1073/pnas.0408159101
52.
Jones-López EC, Namugga O, Mumbowa F, et al. Cough aerosols of Mycobacterium tuberculosis predict new infection: a household contact study. Am J Respir Crit Care Med. 2013;187:1007-15. [PMID: 23306539] doi: 10.1164/rccm.201208-1422OC
53.
Riley EC, Murphy G, Riley RL. Airborne spread of measles in a suburban elementary school. Am J Epidemiol. 1978;107:421-32. [PMID: 665658] doi: 10.1093/oxfordjournals.aje.a112560
54.
Rudnick SN, Milton DK. Risk of indoor airborne infection transmission estimated from carbon dioxide concentration. Indoor Air. 2003;13:237-45. [PMID: 12950586] doi: 10.1034/j.1600-0668.2003.00189.x
55.
Adenaiye OO, Lai J, de Mesquita PJB, et al; University of Maryland StopCOVID Research Group. Infectious SARS-CoV-2 in exhaled aerosols and efficacy of masks during early mild infection. Clin Infect Dis. 2021. [PMID: 34519774] doi: 10.1093/cid/ciab797
56.
Yezli S, Otter JA. Minimum infective dose of the major human respiratory and enteric viruses transmitted through food and the environment. Food Environ Virol. 2011;3:1-30. doi: 10.1007/s12560-011-9056-7
57.
Harvey WT, Carabelli AM, Jackson B, et al; COVID-19 Genomics UK (COG-UK) Consortium. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021;19:409-424. [PMID: 34075212] doi: 10.1038/s41579-021-00573-0
58.
Tran K, Cimon K, Severn M, et al. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One. 2012;7:e35797. [PMID: 22563403] doi: 10.1371/journal.pone.0035797
59.
Chan VW, Ng HH, Rahman L, et al. Transmission of severe acute respiratory syndrome coronavirus 1 and severe acute respiratory syndrome coronavirus 2 during aerosol-generating procedures in critical care: a systematic review and meta-analysis of observational studies. Crit Care Med. 2021;49:1159-1168. [PMID: 33749225] doi: 10.1097/CCM.0000000000004965
60.
Wilson NM, Marks GB, Eckhardt A, et al. The effect of respiratory activity, non-invasive respiratory support and facemasks on aerosol generation and its relevance to COVID-19. Anaesthesia. 2021;76:1465-1474. [PMID: 33784793] doi: 10.1111/anae.15475
61.
Brown J, Gregson FKA, Shrimpton A, et al. A quantitative evaluation of aerosol generation during tracheal intubation and extubation. Anaesthesia. 2021;76:174-181. [PMID: 33022093] doi: 10.1111/anae.15292
62.
O’Neil CA, Li J, Leavey A, et al; Centers for Disease Control and Prevention Epicenters Program. Characterization of aerosols generated during patient care activities. Clin Infect Dis. 2017;65:1335-1341. [PMID: 29017249] doi: 10.1093/cid/cix535
63.
Gaeckle NT, Lee J, Park Y, et al. Aerosol generation from the respiratory tract with various modes of oxygen delivery. Am J Respir Crit Care Med. 2020;202:1115-1124. [PMID: 32822208] doi: 10.1164/rccm.202006-2309OC
64.
Sajgalik P, Garzona-Navas A, Csécs I, et al. Characterization of aerosol generation during various intensities of exercise. Chest. 2021;160:1377-1387. [PMID: 33957100] doi: 10.1016/j.chest.2021.04.041
65.
Klompas M, Baker M, Rhee C. What is an aerosol-generating procedure. JAMA Surg. 2021;156:113-114. [PMID: 33320188] doi: 10.1001/jamasurg.2020.6643
66.
Dharmadhikari AS, Mphahlele M, Stoltz A, et al. Surgical face masks worn by patients with multidrug-resistant tuberculosis: impact on infectivity of air on a hospital ward. Am J Respir Crit Care Med. 2012;185:1104-9. [PMID: 22323300] doi: 10.1164/rccm.201107-1190OC
67.
Klompas M, Baker MA, Griesbach D, et al. Transmission of SARS-CoV-2 from asymptomatic and presymptomatic individuals in healthcare settings despite medical masks and eye protection. Clin Infect Dis. 2021. [PMID: 33704451] doi: 10.1093/cid/ciab218
68.
Goldberg L, Levinsky Y, Marcus N, et al. SARS-CoV-2 infection among health care workers despite the use of surgical masks and physical distancing—the role of airborne transmission. Open Forum Infect Dis. 2021;8:ofab036. [PMID: 33732749] doi: 10.1093/ofid/ofab036
69.
Oksanen LAH, Sanmark E, Oksanen SA, et al. Sources of healthcare workers' COVID-19 infections and related safety guidelines. Int J Occup Med Environ Health. 2021;34:239-249. [PMID: 33847307] doi: 10.13075/ijomeh.1896.01741
70.
Sickbert-Bennett EE, Samet JM, Clapp PW, et al. Filtration efficiency of hospital face mask alternatives available for use during the COVID-19 pandemic. JAMA Intern Med. 2020;180:1607-1612. [PMID: 32780113] doi: 10.1001/jamainternmed.2020.4221
71.
Brooks JT, Beezhold DH, Noti JD, et al. Maximizing fit for cloth and medical procedure masks to improve performance and reduce SARS-CoV-2 transmission and exposure, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:254-257. [PMID: 33600386] doi: 10.15585/mmwr.mm7007e1
72.
Gragnani CM, Fernandes P, Waxman DA. Validation of Centers for Disease Control and Prevention level 3 risk classification for healthcare workers exposed to severe acute respiratory coronavirus virus 2 (SARS-CoV-2). Infect Control Hosp Epidemiol. 2021;42:483-485. [PMID: 33280637] doi: 10.1017/ice.2020.1353
73.
Hetemäki I, Kääriäinen S, Alho P, et al. An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021. Euro Surveill. 2021;26. [PMID: 34328076] doi: 10.2807/1560-7917.ES.2021.26.30.2100636
74.
Shitrit P, Zuckerman NS, Mor O, et al. Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021. Euro Surveill. 2021;26. [PMID: 34596015] doi: 10.2807/1560-7917.ES.2021.26.39.2100822
75.
Chu DK, Akl EA, Duda S, et al; COVID-19 Systematic Urgent Review Group Effort (SURGE) study authors. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020;395:1973-1987. [PMID: 32497510] doi: 10.1016/S0140-6736(20)31142-9
76.
Sims MD, Maine GN, Childers KL, et al. Coronavirus disease 2019 (COVID-19) seropositivity and asymptomatic rates in healthcare workers are associated with job function and masking. Clin Infect Dis. 2021;73:S154-S162. [PMID: 33150375] doi: 10.1093/cid/ciaa1684
77.
Jacob JT, Baker JM, Fridkin SK, et al. Risk factors associated with SARS-CoV-2 seropositivity among US health care personnel. JAMA Netw Open. 2021;4:e211283. [PMID: 33688967] doi: 10.1001/jamanetworkopen.2021.1283
78.
Braun KM, Moreno GK, Buys A, et al. Viral sequencing to investigate sources of SARS-CoV-2 infection in US healthcare personnel. Clin Infect Dis. 2021;73:e1329-e1336. [PMID: 33857303] doi: 10.1093/cid/ciab281
79.
Shah ASV, Wood R, Gribben C, et al. Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study. BMJ. 2020;371:m3582. [PMID: 33115726] doi: 10.1136/bmj.m3582
80.
Mo Y, Eyre DW, Lumley SF, et al. Transmission dynamics of SARS-CoV-2 in the hospital setting. medRxiv. Preprint posted online 1 May 2021. doi: 10.1101/2021.04.28.21256245
81.
McEllistrem MC, Clancy CJ, Buehrle DJ, et al. SARS-CoV-2 is associated with high viral loads in asymptomatic and recently symptomatic healthcare workers. PLoS One. 2021;16:e0248347. [PMID: 33735264] doi: 10.1371/journal.pone.0248347
82.
Radonovich LJ Jr, Simberkoff MS, Bessesen MT, et al; ResPECT investigators. N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial. JAMA. 2019;322:824-833. [PMID: 31479137] doi: 10.1001/jama.2019.11645
83.
Menzies D, Fanning A, Yuan L, et al. Hospital ventilation and risk for tuberculous infection in Canadian health care workers. Canadian Collaborative Group in Nosocomial Transmission of TB. Ann Intern Med. 2000;133:779-89. [PMID: 11085840] doi: 10.7326/0003-4819-133-10-200011210-00010
84.
Tsui BCH, Pan S. Are aerosol-generating procedures safer in an airborne infection isolation room or operating room? [Letter]. Br J Anaesth. 2020;125:e485-e487. [PMID: 33036758] doi: 10.1016/j.bja.2020.09.011
85.
Botelho-Nevers E, Gautret P, Biellik R, et al. Nosocomial transmission of measles: an updated review. Vaccine. 2012;30:3996-4001. [PMID: 22521843] doi: 10.1016/j.vaccine.2012.04.023
86.
Leclair JM, Zaia JA, Levin MJ, et al. Airborne transmission of chickenpox in a hospital. N Engl J Med. 1980;302:450-3. [PMID: 7351951] doi: 10.1056/NEJM198002213020807
87.
Coronado VG, Beck-Sague CM, Hutton MD, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis. 1993;168:1052-5. [PMID: 8104226] doi: 10.1093/infdis/168.4.1052
88.
Klompas M, Ye S, Vaidya V, et al. Association between airborne infection isolation room utilization rates and healthcare worker COVID-19 infections in two academic hospitals. Clin Infect Dis. 2021. [PMID: 34599821] doi: 10.1093/cid/ciab849
89.
Meyerowitz EA, Richterman A. A defense of the classical model of transmission of respiratory pathogens. Clin Infect Dis. 2021;73:1318. [PMID: 33433558] doi: 10.1093/cid/ciab016
90.
Coleman BL, Ng W, Mahesh V, et al. Active surveillance for influenza reduces but does not eliminate hospital exposure to patients with influenza. Infect Control Hosp Epidemiol. 2017;38:387-392. [PMID: 28069087] doi: 10.1017/ice.2016.321
91.
Rickman HM, Rampling T, Shaw K, et al. Nosocomial transmission of coronavirus disease 2019: a retrospective study of 66 hospital-acquired cases in a London teaching hospital. Clin Infect Dis. 2021;72:690-693. [PMID: 32562422] doi: 10.1093/cid/ciaa816
92.
Read JM, Green CA, Harrison EM, et al; ISARIC4C investigators. Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave [Letter]. Lancet. 2021;398:1037-1038. [PMID: 34391505] doi: 10.1016/S0140-6736(21)01786-4
93.
Meredith LW, Hamilton WL, Warne B, et al. Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study. Lancet Infect Dis. 2020;20:1263-1271. [PMID: 32679081] doi: 10.1016/S1473-3099(20)30562-4
94.
Choi SH, Hong SB, Ko GB, et al. Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med. 2012;186:325-32. [PMID: 22700859] doi: 10.1164/rccm.201112-2240OC
95.
Micek ST, Chew B, Hampton N, et al. A case-control study assessing the impact of nonventilated hospital-acquired pneumonia on patient outcomes. Chest. 2016;150:1008-1014. [PMID: 27102181] doi: 10.1016/j.chest.2016.04.009
96.
Shorr AF, Zilberberg MD, Micek ST, et al. Viruses are prevalent in non-ventilated hospital-acquired pneumonia. Respir Med. 2017;122:76-80. [PMID: 27993295] doi: 10.1016/j.rmed.2016.11.023
97.
Somsen GA, van Rijn C, Kooij S, et al. Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission. Lancet Respir Med. 2020;8:658-659. [PMID: 32473123] doi: 10.1016/S2213-2600(20)30245-9
98.
Sietsema M, Radonovich L, Hearl FJ, et al. A control banding framework for protecting the US workforce from aerosol transmissible infectious disease outbreaks with high public health consequences. Health Secur. 2019;17:124-132. [PMID: 30942621] doi: 10.1089/hs.2018.0103

Information & Authors

Information

Published In

cover image Annals of Internal Medicine
Annals of Internal Medicine
Volume 174Number 12December 2021
Pages: 1710 - 1718

History

Published online: 9 November 2021
Published in issue: December 2021

Keywords

Authors

Affiliations

Michael Klompas, MD, MPH https://orcid.org/0000-0001-8641-4498
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, and Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts (M.K., C.R., M.A.B.)
Donald K. Milton, MD, DrPH https://orcid.org/0000-0002-0550-7834
Maryland Institute for Applied Environmental Health, School of Public Health, University of Maryland, College Park, Maryland (D.K.M.)
Chanu Rhee, MD, MPH
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, and Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts (M.K., C.R., M.A.B.)
Meghan A. Baker, MD, ScD
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, and Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts (M.K., C.R., M.A.B.)
Surbhi Leekha, MBBS, MPH https://orcid.org/0000-0002-4565-6439
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland (S.L.).
Grant Support: By grant 6U54CK000484-04-02 from the Centers for Disease Control and Prevention (Drs. Klompas, Rhee, and Baker); grants from the National Institute of Allergy and Infectious Diseases Centers of Excellence for Influenza Research and Surveillance (HHSN272201400008C), the Centers of Excellence for Influenza Research and Response (75N93021C00014), the Centers for Disease Control and Prevention (200-2020-09528), and the National Science Foundation (2034755) (Dr. Milton); and grant 6 U01CK000556-02-02 from the Centers for Disease Control and Prevention (Dr. Leekha).
Corresponding Author: Michael Klompas, MD, MPH, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA 02215; e-mail, [email protected].
Author Contributions: Conception and design: M. Klompas, C. Rhee, M.A. Baker, S. Leekha.
Analysis and interpretation of the data: S. Leekha.
Drafting of the article: M. Klompas, S. Leekha.
Critical revision of the article for important intellectual content: M. Klompas, D.K. Milton, C. Rhee, M.A. Baker, S. Leekha.
Final approval of the article: M. Klompas, D.K. Milton, C. Rhee, M.A. Baker, S. Leekha.
This article was published at Annals.org on 9 November 2021.

Metrics & Citations

Metrics

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format





Download article citation data for:
Michael Klompas, Donald K. Milton, Chanu Rhee, et al. Current Insights Into Respiratory Virus Transmission and Potential Implications for Infection Control Programs: A Narrative Review. Ann Intern Med.2021;174:1710-1718. [Epub 9 November 2021]. doi:10.7326/M21-2780

View More

Get Access

Login Options:
Purchase

You will be redirected to acponline.org to sign-in to Annals to complete your purchase.

Access to EPUBs and PDFs for FREE Annals content requires users to be registered and logged in. A subscription is not required. You can create a free account below or from the following link. You will be redirected to acponline.org to create an account that will provide access to Annals. If you are accessing the Free Annals content via your institution's access, registration is not required.

Create your Free Account

You will be redirected to acponline.org to create an account that will provide access to Annals.

View options

PDF/ePub

View PDF/ePub

Related in ACP Journals

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media